Clinical trial · Interventional
VR for Symptom Control and Wellbeing
The Use of Virtual Reality for Symptom Control and Wellbeing in Palliative Care and Oncology Patients
NCT04821466CI-TRIAL-00071561completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To investigate the effect that a Virtual Reality experience can have on patient symptoms and wellbeing for palliative care and oncology inpatients
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| End Stage Cancer | — | UNRESOLVED | — |
| Hematologic Malignancy | Hematopoietic and Lymphoid Cell Neoplasm | ALIAS | 0.90 |
| Oncology | — | UNRESOLVED | — |
| Palliative Care | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Virtual Reality Headset to provide a Virtual Reality Experience | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Virtual Reality Headset
- description
- VR headset, programmed with a selection of 7 wellbeing programs to identify if use will improve participants wellbeing
- interventionNames
- Device: Virtual Reality Headset to provide a Virtual Reality Experience
Primary outcomes (1)
- measure
- ESAS-r Quality of Life Scores
- timeFrame
- Time 0 & Time 60 minutes
- description
- Change in ESAS-r QoL score between start and finish of Virtual Reality experience. 0 = No symptoms to 10 = Worst Symptom
Secondary outcomes (2)
- measure
- Quantitative clinician experience of VR intervention
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion criteria * \> 18 years of age * Inpatient at RCHT know to the palliative care team * Able to consent * Able to speak and understand the English language * Able to use the virtual reality system * Able to complete ESAS-r Questionnaire Exclusion criteria * \<18 years of age * Patient unable to consent * Patient unable to speak English * Unable to use the virtual reality system (e.g. visually impaired) * Known Epilepsy or seizures or suspected predisposition to seizures (e.g. Brain metastasis)
References
Publications (1)
- DERIVEDMoon NO, Henstridge-Blows JR, Sprecher EA, Thomas E, Byfield A, McGrane J. 'Godrevy Project': virtual reality for symptom control and well-being in oncology and palliative care - a non-randomised pre-post interventional trial. BMJ Oncol. 2023 Dec 18;2(1):e000160. doi: 10.1136/bmjonc-2023-000160. eCollection 2023. PMID 39886490